To the Editor We write to report our failure to disclose a potential conflict of interest in our disclosure statements published in the article, “Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins,” that was published in JAMA Oncology online first on July 12, 2018, and with the October 2018 issue.1 This validation study found that a risk prediction model that included 4 protein biomarkers that was developed in a cohort of US individuals at high risk of lung cancer outperformed a model based on smoking history alone when validated using prediagnostic samples from 2 European cohorts.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Hanash SM, Feng Z, Taguchi A. Failure to Disclose Potential Conflict of Interest—Letter of Explanation. JAMA Oncol. 2019;5(12):1811. doi:10.1001/jamaoncol.2019.5259
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: